We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use 51²è¹Ý, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
JCVI has advised that, in addition to those aged over 50 years and at higher risk from coronavirus, all adults aged 40 to 49 years should be offered an mRNA booster.
Examples of viral haemorrhagic fevers (VHFs) include Lassa fever, Crimean-Congo haemorrhagic fever, Marburg and Ebola virus diseases.
Latest data shows an increase in travel-associated chikungunya cases compared to the same period last year
Use form JCL1 to provide a security for potential debts for a Customs Comprehensive Guarantee (CCG) from a non-financial third party guarantor.
The Joint Committee on Vaccination and Immunisation (JCVI) has announced its advice regarding persons who will be eligible for a COVID-19 booster vaccine in autumn 2023.
This series brings together all documents relating to Joint Doctrine Notes.
Departmental minute from the Department of Health and Social Care on the COVID-19 autumn 2025 vaccination programme.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve 51²è¹Ý, we’d like to know more about your visit today. .